Author(s): McCarthy E.M.; Parker B.; Bruce I.N.; Sutton E.; Nesbit S.; Jayne D.; Griffiths B.; Isenberg D.A.; Rahman A.; Gordon C.; D'Cruz D.P.; Rhodes B.; Lanyon P.; Vital E.M.; Yee C.-S.; Edwards C.J.; Teh L.-S.; Akil M.; McHugh N.J.; Zoma A.

Source: Rheumatology (United Kingdom); Jun 2017; vol. 56 (no. 6); p. 1049

Publication Date: Jun 2017

Publication Type(s): Erratum

Abstract:The title of the above paper has been adapted after publication ahead of print. The original title of The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence has been adapted to The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.Copyright © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
​
Database: EMBASE

​Author(s): McCarthy E.M.; Parker B.; Bruce I.N.; Sutton E.; Nesbit S.; Jayne D.; Griffiths B.; Isenberg D.A.; Rahman A.; Gordon C.; D'Cruz D.P.; Rhodes B.; Lanyon P.; Vital E.M.; Yee C.-S.; Edwards C.J.; Teh L.-S.; Akil M.; McHugh N.J.; Zoma A.

Source: Rheumatology (United Kingdom); Jun 2017; vol. 56 (no. 6); p. 1041-1043

Publication Date: Jun 2017

Publication Type(s): Letter
​
Database: EMBASE